Publications 2005 pour pdf

Davido A, Hallali P, Darmon JY, Robinet C, Jullien JL, Corone P. Pleuropericardial cyst two-dimensio-nal echography and C.A.T. scan of a case. Coeur-Paris 1987 ; 18 : 35-8.
Andrivet P, Adnot S, Brun-Buisson C, Chabrier E, Darmon JY, Braquet P, Lemaire F. Involvement ofANF in the acute antidiuresis during PEEP ventilation. J Appl Physiol 1988 ; 65 : 1967-1974.
Saada M, Catoire P, Deleuze P, Darmon JY, Gabriel I, Bonnet F. Diagnosis of severe pulmonary embo-lism by transesophageal echocardiography. Ann Fr Anesth Reanim 1990 ; 9 : 547-49.
Roupie E, Darmon JY, Brochard L, Saada M, Rekik N, Brun-Buisson C. Fluconazole therapy of candidalnative valve endocarditis. Eur J Clin Microbiol Inf Dis 1991 ; 10 : 458-59.
Darmon JY, Rauss A, Dreyfuss D, Bleichneir G, Elkharrat D, Schlemmer B, Tenaillon A, Brun-Buisson C, Huet Y. Evaluation of risk factors for laryngeal edema after tracheal extubation inadults and its prevention by dexamethasone. A placebo-controlled, double-blind, multicenter study.
Anesthesiology 1992 ; 77 : 245-51.
Darmon JY. Required sample-size for randomized clinical trials. Anesthesiology 1993 ; 78 : 610.
Mentec H, Chosidow O, Lafaurie P, Darmon JY, Simon M, Roujeau JC, Brun-Buisson C. Simultaneousarm and leg necrotizing fasciitis due to Neisseria meningitidis : a case report and review of the litera-ture. Ann Dermatol Venerol 1993 ; 120 : 889-91.
Aragao I, Darmon JY, Brun-Buisson C. Adaptation of tissue oxygen extraction in septic and cardioge-nic shock. Rev Portug Med Intens 1993 ; 2 : 19-23.
Dubois-Randé JL, Artigou JY, Darmon JY, Habbal R, Manuel C, Tayarani I, Castaigne A, GrosgogeatY. Oxidative stress in patients with unstable angina. Eur Heart J 1994 ; 15 : 179-83.
Darmon JY. Activateurs des canaux potassiques et pathologie cardiovasculaire. Le nicorandil (IKO-REL®) dans l'insuffisance coronaire. Revue de l'ADPHSO 1994 ; 19 : 91-7.
Witchitz S, Darmon JY. Nicorandil safety in the long term treatment of coronary heart disease.
Cardiovasc Drugs Ther 1995 ; 9 : 237-43.
Lenique F, Teboul JL, Darmon JY, Mercat A, Richard C. Evaluation of haemodynamic and oxygen-deri-ved parameters to predict outcome in patients with acute heart failure. Clinical Intensive Care 1995 ;6 : 148-52.
Planes A, Vochelle N, Darmon JY, Fagola M, Bellaud M, Huet Y. Risk of deep-venous thrombosis afterhospital discharge in patients having undergone total hip replacement : randomised comparison ofenoxaparin versus placebo. Lancet 1996 ; 348 : 224-28.
Planes A, Vochelle N, Darmon JY. Post-discharge deep-vein thrombosis after orthopaedic surgery.
Lancet 1996 ; 348 : 117.
Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Jambon C, Leizorovicz A, Nguyen H,Olsson CG, Turpie AG, Weisslinger N. A comparison of enoxaparin with placebo for the prevention ofvenous thromboembolism in acutely ill medical patients. N Engl J Med 1999 ; 341 : 793-800.
Witchitz S, Cohen-Solal A, Dartois N, Weisslinger N, Juste K, Darmon JY, for the CELICARD Group.
Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodila-tory properties. Am J Cardiol 2000 ; 85 : 1467-71.
Samama MM for the Sirius Study Group , Darmon JY, De Vathaire F, Huet Y, Landauer D, Samama MM,Simonneau G, Wainstein JP, Weisslinger N. An epidemiologic study of risk factors for dep vein thrombo-sis in medical outpatients. The Sirius Study. Arch Intern Med 2000 ; 160 : 3415-20.
Mismetti P, Laporte S, Darmon JY, Buchmüller A, Decousus H. Meta-analysis of low molecular weightheparin in the prevention of venous thromboembolism in general surgery. Br J Surg 2001 ;88 :1-18. Lepercq J, Conard J, Borel-Derlon A, Darmon JY, Boudignat O, Francoual C, Priollet P, Cohen C, YvelinN, Schved JF, Tournaire M, Borg JY. Venous thromboembolism during pregnancy : a retrospectve studyof enoxaparin in 624 pregnancies. Br J Obstet Gynaecol 2001 ; 108 : 1134-40.



The Center for Psychotropic Drugs and Children Health and Health Care in Schools A 2007 Update The School of Public Health & Health Services December 2007 THE GEORGE WASHINGTON UNIVERSITY References Background The safe and effective use of medications for the treatment of certain medical conditions and1 National Association of School Nurses. Position statemen

Bse announcements-latest news-september 20009 - may 201

June 28, 2010 VENUS REMEDIES ENTERS AUSTRALASIA REGION WITH GRANT OF PATENT FOR POTENTOX FROM NEW ZEALAND Venus Remedies has marked its presence in the region of Australasia by receiving a patent from Commissioner of Patents , Trademarks & Design, Intellectual Property office of New Zealand for its antibiotic Potentox, a fixed dose combination of cefepime and amikacin. This unique

Copyright © 2011-2018 Health Abstracts